摘要 |
The present invention provides HIV aspartyl protease inhibitors of the formula;and when the compound of formula I comprises an amino group, pharmaceutically acceptable ammonium salts thereof, wherein n is 3 or 4, wherein R<HIL><PDAT>1 </SB><PDAT>may be, for example, iso-butyl, wherein X and Y, same or different, may be, for example, NH<HIL><PDAT>2 </SB><PDAT>and F, and wherein R<HIL><PDAT>2 </SB><PDAT>and R<HIL><PDAT>3 </SB><PDAT>are as defined herein.</PTEXT>
|